Covid-19 Impact on Global Bacteriophage Therapy Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2026

The research team projects that the Bacteriophage Therapy market size will grow from XXX in 2019 to XXX by 2026, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2026.

The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.

By Market Players:
Armata Pharmaceuticals, Inc.
Locus Biosciences, Inc.
Intralytix, Inc.
Eliava Biopreparations Ltd.
InnoPhage, Ltd
Pherecydes Pharma
Eligo Bioscience SA
Nextbiotics
Phagelux Inc.
TechnoPhage
Intodeworld, Inc.
Fixed-phage Ltd.
Phagomed Biopharma GmbH.
ContraFect Corporation
BiomX Ltd.
EnBiotix, Inc.
PhagePro, Inc.
Micreos BV
Phi Therapeutics
Adaptive Phage Therapeutics, Inc.

By Type
Oral
Topical
Parenteral

By Application
Organ Transplantation
Bacterial Infections
Alcoholic Hepatitis
Other

By Regions/Countries:
North America
United States
Canada
Mexico

East Asia
China
Japan
South Korea

Europe
Germany
United Kingdom
France
Italy

South Asia
India

Southeast Asia
Indonesia
Thailand
Singapore

Middle East
Turkey
Saudi Arabia
Iran

Africa
Nigeria
South Africa

Oceania
Australia

South America

Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.

The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Bacteriophage Therapy 2015-2020, and development forecast 2021-2026 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.

Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2026. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Bacteriophage Therapy Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the Bacteriophage Therapy Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Bacteriophage Therapy market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

1 Market Overview
1.1 Bacteriophage Therapy Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Bacteriophage Therapy Revenue by Type: 2015 Versus 2020
1.2.2 Oral
1.2.3 Topical
1.2.4 Parenteral
1.3 Market Analysis by Application
1.3.1 Overview: Global Bacteriophage Therapy Revenue by Application: 2015-2020
1.3.2 Organ Transplantation
1.3.3 Bacterial Infections
1.3.4 Alcoholic Hepatitis
1.3.5 Other
1.4 Overview of Global Bacteriophage Therapy Market
1.4.1 Global Bacteriophage Therapy Market Status and Outlook (2015-2026)
1.4.2 North America
1.4.3 East Asia
1.4.4 Europe
1.4.5 South Asia
1.4.6 Southeast Asia
1.4.7 Middle East
1.4.8 Africa
1.4.9 Oceania
1.4.10 South America
1.4.11 Rest of the World
1.5 COVID-19 Outbreak: Bacteriophage Therapy Industry Impact
1.5.1 COVID-19 Potential Implications for the Bacteriophage Therapy
1.5.2 Growth Opportunities Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Growth Drivers
1.6 Leading Market Players Recent Reaction to COVID-19
1.7 Recent Market Price Analysis Reaction to COVID-19
1.8 Key Countries Responses to COVID-19 Outbreak
2 Company Profiles and Key Figures in Bacteriophage Therapy Business
2.1 Armata Pharmaceuticals, Inc.
2.1.1 Armata Pharmaceuticals, Inc. Company Profile
2.1.2 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Product Specification
2.1.3 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
2.2 Locus Biosciences, Inc.
2.2.1 Locus Biosciences, Inc. Company Profile
2.2.2 Locus Biosciences, Inc. Bacteriophage Therapy Product Specification
2.2.3 Locus Biosciences, Inc. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
2.3 Intralytix, Inc.
2.3.1 Intralytix, Inc. Company Profile
2.3.2 Intralytix, Inc. Bacteriophage Therapy Product Specification
2.3.3 Intralytix, Inc. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
2.4 Eliava Biopreparations Ltd.
2.4.1 Eliava Biopreparations Ltd. Company Profile
2.4.2 Eliava Biopreparations Ltd. Bacteriophage Therapy Product Specification
2.4.3 Eliava Biopreparations Ltd. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
2.5 InnoPhage, Ltd
2.5.1 InnoPhage, Ltd Company Profile
2.5.2 InnoPhage, Ltd Bacteriophage Therapy Product Specification
2.5.3 InnoPhage, Ltd Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
2.6 Pherecydes Pharma
2.6.1 Pherecydes Pharma Company Profile
2.6.2 Pherecydes Pharma Bacteriophage Therapy Product Specification
2.6.3 Pherecydes Pharma Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
2.7 Eligo Bioscience SA
2.7.1 Eligo Bioscience SA Company Profile
2.7.2 Eligo Bioscience SA Bacteriophage Therapy Product Specification
2.7.3 Eligo Bioscience SA Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
2.8 Nextbiotics
2.8.1 Nextbiotics Company Profile
2.8.2 Nextbiotics Bacteriophage Therapy Product Specification
2.8.3 Nextbiotics Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
2.9 Phagelux Inc.
2.9.1 Phagelux Inc. Company Profile
2.9.2 Phagelux Inc. Bacteriophage Therapy Product Specification
2.9.3 Phagelux Inc. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
2.10 TechnoPhage
2.10.1 TechnoPhage Company Profile
2.10.2 TechnoPhage Bacteriophage Therapy Product Specification
2.10.3 TechnoPhage Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
2.11 Intodeworld, Inc.
2.11.1 Intodeworld, Inc. Company Profile
2.11.2 Intodeworld, Inc. Bacteriophage Therapy Product Specification
2.11.3 Intodeworld, Inc. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
2.12 Fixed-phage Ltd.
2.12.1 Fixed-phage Ltd. Company Profile
2.12.2 Fixed-phage Ltd. Bacteriophage Therapy Product Specification
2.12.3 Fixed-phage Ltd. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
2.13 Phagomed Biopharma GmbH.
2.13.1 Phagomed Biopharma GmbH. Company Profile
2.13.2 Phagomed Biopharma GmbH. Bacteriophage Therapy Product Specification
2.13.3 Phagomed Biopharma GmbH. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
2.14 ContraFect Corporation
2.14.1 ContraFect Corporation Company Profile
2.14.2 ContraFect Corporation Bacteriophage Therapy Product Specification
2.14.3 ContraFect Corporation Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
2.15 BiomX Ltd.
2.15.1 BiomX Ltd. Company Profile
2.15.2 BiomX Ltd. Bacteriophage Therapy Product Specification
2.15.3 BiomX Ltd. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
2.16 EnBiotix, Inc.
2.16.1 EnBiotix, Inc. Company Profile
2.16.2 EnBiotix, Inc. Bacteriophage Therapy Product Specification
2.16.3 EnBiotix, Inc. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
2.17 PhagePro, Inc.
2.17.1 PhagePro, Inc. Company Profile
2.17.2 PhagePro, Inc. Bacteriophage Therapy Product Specification
2.17.3 PhagePro, Inc. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
2.18 Micreos BV
2.18.1 Micreos BV Company Profile
2.18.2 Micreos BV Bacteriophage Therapy Product Specification
2.18.3 Micreos BV Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
2.19 Phi Therapeutics
2.19.1 Phi Therapeutics Company Profile
2.19.2 Phi Therapeutics Bacteriophage Therapy Product Specification
2.19.3 Phi Therapeutics Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
2.20 Adaptive Phage Therapeutics, Inc.
2.20.1 Adaptive Phage Therapeutics, Inc. Company Profile
2.20.2 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Product Specification
2.20.3 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Bacteriophage Therapy Sales and Market Share by Manufacturer (2015-2020)
3.2 Global Bacteriophage Therapy Revenue and Market Share by Manufacturer (2015-2020)
3.3 Market Competition Trend
4 Sales by Region
4.1 Global Bacteriophage Therapy Sales Volume Market Share by Region (2015-2020)
4.2 Global Bacteriophage Therapy Sales Revenue Market Share by Region (2015-2020)
4.3 North America Bacteriophage Therapy Sales Volume
4.3.1 North America Bacteriophage Therapy Sales Volume Growth Rate (2015-2020)
4.3.2 North America Bacteriophage Therapy Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4.4 East Asia Bacteriophage Therapy Sales Volume
4.4.1 East Asia Bacteriophage Therapy Sales Volume Growth Rate (2015-2020)
4.4.2 East Asia Bacteriophage Therapy Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Bacteriophage Therapy Sales Volume (2015-2020)
4.5.1 Europe Bacteriophage Therapy Sales Volume Growth Rate (2015-2020)
4.5.2 Europe Bacteriophage Therapy Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4.6 South Asia Bacteriophage Therapy Sales Volume (2015-2020)
4.6.1 South Asia Bacteriophage Therapy Sales Volume Growth Rate (2015-2020)
4.6.2 South Asia Bacteriophage Therapy Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4.7 Southeast Asia Bacteriophage Therapy Sales Volume (2015-2020)
4.7.1 Southeast Asia Bacteriophage Therapy Sales Volume Growth Rate (2015-2020)
4.7.2 Southeast Asia Bacteriophage Therapy Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4.8 Middle East Bacteriophage Therapy Sales Volume (2015-2020)
4.8.1 Middle East Bacteriophage Therapy Sales Volume Growth Rate (2015-2020)
4.8.2 Middle East Bacteriophage Therapy Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4.9 Africa Bacteriophage Therapy Sales Volume (2015-2020)
4.9.1 Africa Bacteriophage Therapy Sales Volume Growth Rate (2015-2020)
4.9.2 Africa Bacteriophage Therapy Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4.10 Oceania Bacteriophage Therapy Sales Volume (2015-2020)
4.10.1 Oceania Bacteriophage Therapy Sales Volume Growth Rate (2015-2020)
4.10.2 Oceania Bacteriophage Therapy Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4.11 South America Bacteriophage Therapy Sales Volume (2015-2020)
4.11.1 South America Bacteriophage Therapy Sales Volume Growth Rate (2015-2020)
4.11.2 South America Bacteriophage Therapy Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4.12 Rest of the World Bacteriophage Therapy Sales Volume (2015-2020)
4.12.1 Rest of the World Bacteriophage Therapy Sales Volume Growth Rate (2015-2020)
4.12.2 Rest of the World Bacteriophage Therapy Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
5 North America
5.1 North America Bacteriophage Therapy Consumption by Countries
5.2 United States
5.3 Canada
5.4 Mexico
6 East Asia
6.1 East Asia Bacteriophage Therapy Consumption by Countries
6.2 China
6.3 Japan
6.4 South Korea
7 Europe
7.1 Europe Bacteriophage Therapy Consumption by Countries
7.2 Germany
7.3 United Kingdom
7.4 France
7.5 Italy
7.6 Russia
7.7 Spain
7.8 Netherlands
7.9 Switzerland
7.10 Poland
8 South Asia
8.1 South Asia Bacteriophage Therapy Consumption by Countries
8.2 India
8.3 Pakistan
8.4 Bangladesh
9 Southeast Asia
9.1 Southeast Asia Bacteriophage Therapy Consumption by Countries
9.2 Indonesia
9.3 Thailand
9.4 Singapore
9.5 Malaysia
9.6 Philippines
9.7 Vietnam
9.8 Myanmar
10 Middle East
10.1 Middle East Bacteriophage Therapy Consumption by Countries
10.2 Turkey
10.3 Saudi Arabia
10.4 Iran
10.5 United Arab Emirates
10.6 Israel
10.7 Iraq
10.8 Qatar
10.9 Kuwait
10.10 Oman
11 Africa
11.1 Africa Bacteriophage Therapy Consumption by Countries
11.2 Nigeria
11.3 South Africa
11.4 Egypt
11.5 Algeria
11.6 Morocco
12 Oceania
12.1 Oceania Bacteriophage Therapy Consumption by Countries
12.2 Australia
12.3 New Zealand
13 South America
13.1 South America Bacteriophage Therapy Consumption by Countries
13.2 Brazil
13.3 Argentina
13.4 Columbia
13.5 Chile
13.6 Venezuela
13.7 Peru
13.8 Puerto Rico
13.9 Ecuador
14 Rest of the World
14.1 Rest of the World Bacteriophage Therapy Consumption by Countries
14.2 Kazakhstan
15 Sales Volume, Sales Revenue, Sales Price Trend by Type
15.1 Global Bacteriophage Therapy Sales Volume Market Share by Type (2015-2020)
15.2 Global Bacteriophage Therapy Sales Revenue Market Share by Type (2015-2020)
15.3 Global Bacteriophage Therapy Sales Price by Type (2015-2020)
16 Consumption Analysis by Application
16.1 Global Bacteriophage Therapy Consumption Volume by Application (2015-2020)
16.2 Global Bacteriophage Therapy Consumption Value by Application (2015-2020)
17 Production and Supply Forecast
17.1 Global Forecasted Production of Bacteriophage Therapy (2021-2026)
17.2 Global Forecasted Revenue of Bacteriophage Therapy (2021-2026)
17.3 Global Forecasted Price of Bacteriophage Therapy (2015-2026)
17.4 Global Forecasted Production of Bacteriophage Therapy by Region (2021-2026)
17.4.1 North America Bacteriophage Therapy Production, Revenue Forecast (2021-2026)
17.4.2 East Asia Bacteriophage Therapy Production, Revenue Forecast (2021-2026)
17.4.3 Europe Bacteriophage Therapy Production, Revenue Forecast (2021-2026)
17.4.4 South Asia Bacteriophage Therapy Production, Revenue Forecast (2021-2026)
17.4.5 Southeast Asia Bacteriophage Therapy Production, Revenue Forecast (2021-2026)
17.4.6 Middle East Bacteriophage Therapy Production, Revenue Forecast (2021-2026)
17.4.7 Africa Bacteriophage Therapy Production, Revenue Forecast (2021-2026)
17.4.8 Oceania Bacteriophage Therapy Production, Revenue Forecast (2021-2026)
17.4.9 South America Bacteriophage Therapy Production, Revenue Forecast (2021-2026)
17.4.10 Rest of the World Bacteriophage Therapy Production, Revenue Forecast (2021-2026)
17.5 Forecast by Type and by Application (2021-2026)
17.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
17.5.2 Global Forecasted Consumption of Bacteriophage Therapy by Application (2021-2026)
18 Sales Channel, Distributors, Traders and Dealers
18.1 Sales Channel
18.1.1 Direct Channel
18.1.2 Indirect Channel
18.2 Distributors, Traders and Dealers
19 Research Findings and Conclusion
20 Appendix
20.1 Methodology
20.2 Data Source
20.3 Disclaimer
20.4 About US

Frequently Asked Questions About This Report

Choose License Type

Single user
$3,480
Multi User
$5,220
Enterprise User
$6,960
Clear

Each market study on Reports Globe will be revised based on COVID-19 impact analysis

How can we help you?

Our salient features

Best Solution

We will help you understand value propositions of various reports across numerous domains and suggest the best possible solution to suffice your research needs.

Customized Research

Our team of analysts and consultants provide assistance for customized research requirements

Max ROI

Guaranteed maximum assistance to help you get your reports at the optimum prices, thereby ensuring maximum returns on investment.

24/7 Support

24X7 availability to help you through the buying process as well as answer any of your doubts.

Our Clients

We've Received Your Request

We Thank You for filling out your requirements. Our sales team will get in touch with you shortly.